NASDAQ:TLGT - Nasdaq -
0.1735
-0.03 (-13.85%)
The current stock price of TLGT is 0.1735 null. In the past month the price decreased by -55.51%. In the past year, price decreased by -75.14%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 27.44 | 390.99B | ||
JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
PFE | PFIZER INC | 8.46 | 149.04B | ||
SNY | SANOFI-ADR | 13.58 | 136.54B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
GSK | GSK PLC-SPON ADR | 7.78 | 74.77B | ||
ZTS | ZOETIS INC | 27.1 | 72.39B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. The company is headquartered in Buena, New Jersey and currently employs 142 full-time employees. The firm is focused on the development, manufacturing and marketing of a portfolio of generic pharmaceutical products under its own label and private label for other pharmaceutical companies in topical, injectable, complex and other dosage forms. The company also provides contract development and manufacturing services to the prescription and over-the-counter (OTC) pharmaceutical and cosmetic markets. Under the Company's own label, it markets and sells generic topical, and generic and branded generic injectable pharmaceutical products in the United States and Canada. In the United States, the Company markets approximately 37 generic topical pharmaceutical products and one branded injectable pharmaceutical product. In Canada, it markets approximately 24 generic injectable, one generic topical and three generic ophthalmic products.
Teligent Inc
105 Lincoln Avenue
Buena NEW JERSEY 08310 US
CEO: Timothy B. Sawyer
Employees: 142
Company Website: http://www.teligent.com/
Phone: 18566971441.0
The current stock price of TLGT is 0.1735 null. The price decreased by -13.85% in the last trading session.
The exchange symbol of Teligent Inc is TLGT and it is listed on the Nasdaq exchange.
TLGT stock is listed on the Nasdaq exchange.
Teligent Inc (TLGT) has a market capitalization of 16.10M null. This makes TLGT a Nano Cap stock.
Teligent Inc (TLGT) currently has 142 employees.
Teligent Inc (TLGT) has a resistance level at 0.33. Check the full technical report for a detailed analysis of TLGT support and resistance levels.
The Revenue of Teligent Inc (TLGT) is expected to decline by -16.85% in the next year. Check the estimates tab for more information on the TLGT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TLGT does not pay a dividend.
Teligent Inc (TLGT) will report earnings on 2022-03-01.
Teligent Inc (TLGT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.24).
ChartMill assigns a fundamental rating of 3 / 10 to TLGT. TLGT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months TLGT reported a non-GAAP Earnings per Share(EPS) of -7.24. The EPS increased by 27.02% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -197.78% | ||
ROA | -101.27% | ||
ROE | N/A | ||
Debt/Equity | -2.67 |
For the next year, analysts expect an EPS growth of 131.61% and a revenue growth -16.85% for TLGT